Cartherics & panCELLa collaborate to develop safe cell therapy
panCELLa welcomed Cartherics as a capable partner in the addressing of needs of cancer patients…
Split-dosing of DARZALEX initial infusion approved by U.S. FDA
The safety profile of DARZALEX was unchanged in case of a split or single initial…
WuXi – Amicus sign exclusive commercial manufacturing partnership
The deal is to be renewed every two years after its initial five-year term and…
Kuros Biosciences inks new bone graft supply agreement with SeaSpine
The agreement showcases the interest of prominent orthobiologic firms in Kuros technologies. The global partner would…
Precision For Medicine buys ApoCell to expand biomarker capabilities
Precision for Medicine has announced the acquisition of ApoCell, a Houston-based next-generation lab that specializes…
Roche invests an upfront of $125M to expand SQZ cell therapy program
SQZ Biotechnologies, a cell therapy conglomerate renowned for developing novel treatments for a wide range…
Roche unveils NGS AVENIO Tumor Tissue Analysis Kits for research use
The Basel headquartered healthcare company Roche Holding AG has globally launched three next-generation sequencing AVENIO…
Eli Lilly launches Olumiant in India, forays into autoimmune segment
The U.S. based pharmaceutical firm Eli Lilly and Company has reportedly announced to have forayed…
BMS, Compugen announce $12M immunotherapy clinical trial partnership
Bristol-Myers Squibb (BMS) and Compugen, the Israeli genomics-based drug and diagnostic discovery company have made…
Cannabis firm MedMen acquires PharmaCann worth USD 682 million
Los Angeles-based cannabis firm, MedMen Enterprises Inc. has recently announced its binding letter of intent…